Age Verification Required
Pure Pharm Peptides sells research chemicals intended for laboratory use only.
You must be 18 years of age or older to access this website.
By clicking "I am 18 or Older", you confirm that you meet this age requirement.
FOR RESEARCH USE ONLY
NOT FOR HUMAN CONSUMPTION
This verification will be remembered on this device.
Research Library
Scientific overviews of research peptides for laboratory and educational reference. All content is intended strictly for scientific purposes and does not constitute medical advice.
Showing 89 articles
BPC-157 (Body Protection Compound 157): A Review of Research in Experimental Models
A comprehensive overview of BPC-157, a synthetic pentadecapeptide, focusing on its molecular characteristics, research findings, mechanisms of action, and potential applications in tissue repair and angiogenesis studies.
Semaglutide: A GLP-1 Receptor Agonist in Metabolic and Obesity Research
An exploration of Semaglutide, a GLP-1 receptor agonist, focusing on its molecular characteristics, mechanism of action, and diverse research applications in metabolic and obesity studies within experimental models.
AOD-9604: Investigating a Synthetic Peptide in Fat Metabolism Research
AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH176-191) studied in experimental models for its role in fat metabolism and lipolysis, without the growth-promoting effects associated with full-length hGH.
Ipamorelin: A Selective Growth Hormone Secretagogue for Laboratory Research
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, currently under investigation in laboratory research for its potential role in growth hormone release and metabolic regulation without the side effects associated with non-selective secretagogues.
Selank: A Synthetic Heptapeptide Under Investigation for Anxiolytic and Nootropic Properties in Research Models
Selank is a synthetic heptapeptide analogue of tuftsin studied in experimental models for its anxiolytic and nootropic properties, with research focusing on its modulation of GABA, serotonin, and BDNF signaling pathways.
Tirzepatide: A Dual GIP/GLP-1 Receptor Agonist in Metabolic and Obesity Research
Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Preclinical and clinical research has demonstrated significant reductions in body weight and improvements in glycemic control, positioning it as a subject of intense metabolic research.
Retatrutide: Triple Receptor Agonism in Next-Generation Obesity and Metabolic Research
Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Early-phase clinical research has reported unprecedented weight loss magnitudes, positioning it as one of the most potent anti-obesity compounds currently under investigation.
Tesamorelin: A Stabilized GHRH Analogue in Growth Hormone and Metabolic Research
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) stabilized by the addition of a trans-3-hexenoic acid group. Research has focused on its ability to stimulate endogenous growth hormone secretion and reduce visceral adipose tissue, particularly in the context of HIV-associated lipodystrophy.
CJC-1295: A Long-Acting GHRH Analogue for Growth Hormone Axis Research
CJC-1295 is a synthetic GHRH analogue modified with a Drug Affinity Complex (DAC) that enables covalent albumin binding, dramatically extending its half-life to 6–8 days. This extended activity profile makes it a valuable tool for research into sustained growth hormone axis stimulation.
Sermorelin: The GHRH(1-29) Fragment in Growth Hormone Secretagogue Research
Sermorelin is a synthetic 29-amino acid peptide corresponding to the biologically active N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH). It stimulates pituitary GH secretion through the same receptor as native GHRH and has been studied extensively as a diagnostic tool and research compound for GH axis investigation.
GHRP-6: A Ghrelin Mimetic and Growth Hormone Secretagogue in Preclinical Research
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating GH secretion through the GHS-R1a receptor. It is one of the original synthetic growth hormone secretagogues and has been widely used in research to investigate the ghrelin axis and its role in GH regulation, appetite, and metabolic function.
GHRP-2: A Potent Synthetic Growth Hormone Secretagogue in GHS-R1a Research
GHRP-2 is a synthetic hexapeptide growth hormone secretagogue that activates the GHS-R1a receptor with higher potency than GHRP-6. It produces robust, dose-dependent GH release with comparatively less appetite stimulation, making it a widely used research tool for GH axis investigation.
GHK-Cu (Copper Peptide): A Naturally Occurring Tripeptide in Wound Healing and Tissue Regeneration Research
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring human plasma tripeptide with a high affinity for copper ions. Decades of research have implicated it in wound healing, collagen synthesis, anti-inflammatory signaling, and gene expression regulation, making it one of the most studied naturally derived peptides in regenerative medicine research.
NAD+: Nicotinamide Adenine Dinucleotide in Cellular Energy Metabolism and Longevity Research
NAD+ (nicotinamide adenine dinucleotide) is a fundamental coenzyme present in all living cells, essential for energy metabolism, DNA repair, and sirtuin activation. Research has established that NAD+ levels decline with age, and restoration of NAD+ has been studied as a potential intervention in aging-related metabolic decline.
MOTS-c: A Mitochondrial-Derived Peptide in Metabolic Regulation and Exercise Research
MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome, making it one of the few known mitochondrial-derived peptides (MDPs). Research has identified roles in metabolic regulation, insulin sensitivity, exercise response, and aging, positioning MOTS-c as a novel intersection between mitochondrial biology and systemic metabolic control.
CJC-1295/Ipamorelin: Synergistic GHRH and GHRP Combination in Growth Hormone Research
The combination of CJC-1295 and ipamorelin represents a dual-pathway approach to GH axis stimulation, pairing a long-acting GHRH analogue with a selective GHRP. Research has demonstrated that this combination produces synergistic GH release substantially greater than either peptide alone, making it a widely studied protocol in growth hormone research.
TB-500 (Thymosin Beta-4): An Actin-Sequestering Peptide in Tissue Repair and Regeneration Research
TB-500 is a synthetic version of the 43-amino acid peptide Thymosin Beta-4 (Tβ4), one of the most abundant intracellular peptides in mammalian cells. Research has identified roles in actin dynamics, cell migration, wound healing, angiogenesis, and cardiac repair, making TB-500 a subject of significant interest in regenerative medicine research.
BPC-157/TB-500 Combination: Synergistic Peptide Stack in Tissue Repair and Recovery Research
The BPC-157/TB-500 combination pairs two of the most studied regenerative peptides in preclinical research. BPC-157 targets angiogenesis and tendon-to-bone healing through growth factor upregulation, while TB-500 promotes cell migration and actin dynamics. Together, they address complementary aspects of the tissue repair cascade.
Melanotan II (MT-2): A Melanocortin Receptor Agonist in Pigmentation and Sexual Function Research
Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts as a potent agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R. Research has investigated its roles in skin pigmentation, sexual function, appetite regulation, and inflammation.
Semax: An ACTH(4-7) Analogue in Neuroprotection and Cognitive Research
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, developed in Russia and studied for neuroprotective, nootropic, and anxiolytic properties. Research has demonstrated effects on BDNF expression, dopaminergic and serotonergic systems, and cognitive function in animal models and clinical studies.
Glow Blend: A Multi-Peptide Research Formulation for Skin Regeneration and Anti-Aging Investigation
Glow Blend is a research-grade multi-peptide formulation combining GHK-Cu, Epithalon, and complementary peptides studied for their roles in skin regeneration, collagen synthesis, and cellular anti-aging mechanisms. The combination targets multiple pathways in skin biology simultaneously.
Reconstitution of Lyophilized Peptides: A Laboratory Reference Guide
A comprehensive laboratory reference covering the principles, solvents, concentration calculations, standard procedures, and stability considerations for reconstituting lyophilized research peptides. Written for qualified researchers working with peptide compounds in laboratory settings.
Peptide Storage and Stability: A Laboratory Reference Guide
A comprehensive laboratory reference covering degradation pathways, lyophilized and reconstituted peptide storage conditions, freeze-thaw cycle management, peptide-specific stability profiles, and quality assessment protocols for research-grade peptide preparations.
Understanding Peptide Purity and Quality Testing: A Researcher's Guide to HPLC, Mass Spectrometry, and Certificates of Analysis
A comprehensive guide to the analytical methods used to characterize research peptide quality, including HPLC purity analysis, mass spectrometry identity confirmation, and how to evaluate a Certificate of Analysis.
RFK Jr. and the Future of Peptide Compounding: What the FDA's Category 2 Review Means for Research
HHS Secretary RFK Jr. announced that approximately 14 of 19 previously restricted peptides could be legally compounded again by US pharmacies within weeks. Here is what this means for the research community.
BPC-157 Dosage in Preclinical Research: Protocols, Administration Routes, and Study Design
A detailed review of the dosing parameters used in published BPC-157 animal studies, including effective dose ranges, administration routes, and study duration reported in peer-reviewed literature.
TB-500 (Thymosin Beta-4) Dosage in Preclinical Research: Protocols and Administration
A review of dosing parameters, administration routes, and study designs used in published Thymosin Beta-4 (TB-500) preclinical research, drawn from peer-reviewed literature.
How to Reconstitute Lyophilized Peptides: A Step-by-Step Research Protocol
A practical guide to reconstituting lyophilized research peptides using bacteriostatic water, including concentration calculations, sterile technique, and storage recommendations based on established laboratory practice.
CJC-1295 and Ipamorelin in Research: Dosing Parameters and Study Designs
A review of the dosing parameters, administration protocols, and study designs used in published CJC-1295 and Ipamorelin preclinical and clinical research.
BPC-157 vs. TB-500: Comparing Two Tissue Repair Peptides in Preclinical Research
A side-by-side comparison of BPC-157 and TB-500 (Thymosin Beta-4 fragment) based on published preclinical research, examining their distinct mechanisms of action, tissue targets, and research applications.
CJC-1295 vs. Sermorelin: A Comparison of GHRH Analogues in Research
A comparison of CJC-1295 and Sermorelin as growth hormone-releasing hormone analogues, examining their structural differences, pharmacokinetics, and published research applications.
Ipamorelin vs. GHRP-6: Comparing Growth Hormone Secretagogues in Research
A research-based comparison of Ipamorelin and GHRP-6 as growth hormone secretagogue receptor agonists, focusing on their selectivity profiles, side effect differences in animal models, and published research applications.
AOD-9604 vs. Semaglutide: Different Mechanisms in Metabolic Research
A comparison of AOD-9604 and Semaglutide as research tools in metabolic studies, examining their distinct mechanisms of action, published evidence, and appropriate research applications.
What Are Research Peptides? A Beginner's Guide to Synthetic Peptides in Laboratory Science
An introduction to synthetic research peptides — what they are, how they differ from proteins and drugs, why they are used in laboratory research, and the regulatory framework governing their use.
How to Read a Peptide Certificate of Analysis (COA): A Researcher's Guide
A practical guide to interpreting the Certificate of Analysis for research peptides, including how to evaluate HPLC purity data, mass spectrometry identity confirmation, and common red flags that indicate poor quality documentation.
Peptides Studied in Tissue Recovery Research: A Review of the Evidence
A review of the peptides most extensively studied in preclinical tissue recovery and repair models, summarizing the published evidence for each compound's research applications.
BPC-157 and TB-500 in Combination: Research Rationale and Published Evidence
An examination of the scientific rationale for combining BPC-157 and TB-500 in tissue repair research, reviewing their complementary mechanisms and the available published evidence on combined administration.
CJC-1295 and Ipamorelin: The Research Rationale for GHRH + GHSR Agonist Combinations
An examination of the scientific rationale for combining a GHRH analogue (CJC-1295) with a GHSR agonist (Ipamorelin) in growth hormone research, based on the known physiology of GH secretion.
GHK-Cu and NAD+: Two Distinct Pathways in Cellular Repair Research
A review of GHK-Cu (copper peptide) and NAD+ as research tools in cellular repair and aging models, examining their distinct mechanisms and the published evidence for each compound.
Semax and Selank: Neuropeptide Research in Cognitive and Anxiety Models
A review of Semax and Selank as synthetic neuropeptides studied in cognitive function and anxiety models, examining their mechanisms, published evidence, and research applications.
Lyophilized vs. Reconstituted Peptide Storage: Stability and Best Practices
A detailed comparison of lyophilized and reconstituted peptide storage conditions, covering degradation mechanisms, temperature requirements, and practical protocols for maintaining research-grade peptide integrity.
Best Peptides for Metabolic Research: AOD-9604, Semaglutide, MOTS-c, and Tirzepatide
A research-focused overview of peptides studied for metabolic effects, including mechanisms of action, published study findings, and key differences between GLP-1 receptor agonists, lipolytic fragments, and mitochondrial regulators.
Semaglutide vs. Tirzepatide: Mechanisms, Clinical Trial Data, and Research Distinctions
A detailed research comparison of semaglutide (GLP-1 agonist) and tirzepatide (dual GIP/GLP-1 agonist), covering receptor pharmacology, clinical trial outcomes, and the mechanistic basis for their differing efficacy profiles.
Beginner's Guide to Growth Hormone Peptides: GHRH, GHRP, and Secretagogues in Research
An introductory overview of the growth hormone peptide axis for researchers new to the field, covering the distinction between GHRH analogues, GHRPs, and synthetic secretagogues, with key published findings for each class.
Peptide Reconstitution: A Step-by-Step Research Guide
A practical guide to reconstituting lyophilized research peptides, covering bacteriostatic water selection, concentration calculations, and proper storage after reconstitution.
Somatostatin Inhibition: How GHRPs Amplify GH Pulses
A review of somatostatin's role as the primary inhibitor of GH secretion and how GHRP compounds reduce somatostatin tone to amplify GH pulses.
Dosing Frequency and Receptor Sensitivity in Peptide Research
A review of receptor desensitization and downregulation in the context of peptide research, and how dosing frequency affects the sustained efficacy of research compounds.
Red Flags in Peptide COAs: How to Spot Unreliable Suppliers
A practical guide to identifying red flags in Certificate of Analysis documents from peptide suppliers, including missing data, implausible purity claims, and signs of in-house testing bias.
Weight Loss Peptides Compared: AOD-9604, Semaglutide, Tirzepatide Research
A comparative overview of the major research peptides studied for weight loss and metabolic research, examining their mechanisms, evidence bases, and relative efficacy.
BPC-157 and the Gut-Brain Axis: What the Research Shows
An examination of BPC-157's documented interactions with enteric nervous system pathways and central nervous system modulation in preclinical studies.
TB-500 and Actin Binding: The Mechanism Behind Tissue Repair
A detailed look at how TB-500's thymosin beta-4 sequence interacts with G-actin to promote cell migration, angiogenesis, and tissue repair in preclinical models.
GHK-Cu: Copper Peptide Biology and Skin Wound Research
A review of GHK-Cu's copper-binding chemistry, collagen synthesis stimulation, and antioxidant properties documented in published preclinical and clinical research.
Selank: Anxiolytic Peptide Research and GABAergic Modulation
A review of Selank's documented anxiolytic properties, GABA-A receptor modulation, and neurotrophic effects in published preclinical and clinical research.
Semax: BDNF Upregulation and Neuroprotection Research
A review of Semax's documented effects on BDNF expression, neuroprotection, and cognitive function in published preclinical and clinical research.
Epithalon: Telomere Research and the Khavinson Studies
A review of Epithalon's documented effects on telomere length, telomerase activity, and lifespan in preclinical models, based on the published work of Vladimir Khavinson.
NAD+ Precursors vs Direct NAD+ Peptides: What Research Shows
A comparison of NAD+ precursor supplementation (NMN, NR) versus direct NAD+ delivery approaches, examining bioavailability, mechanism differences, and the published evidence base.
How Peptides Signal: Receptor Binding and Second Messenger Cascades
A mechanistic overview of how research peptides interact with cell surface receptors, activate second messenger systems, and produce downstream biological effects.
The GHRH/GHRP Axis: How Growth Hormone Secretagogues Work
A detailed mechanistic review of how GHRH analogues and GHRPs stimulate GH release through complementary receptor pathways and synergistic mechanisms.
Insulin-Like Growth Factor 1 (IGF-1): Downstream Effects of GH Peptides
A review of IGF-1 biology, its role as the primary mediator of GH peptide effects, and the published research on IGF-1 signaling in muscle, bone, and metabolic tissue.
BPC-157 vs TB-500: A Detailed Research Comparison
A side-by-side comparison of BPC-157 and TB-500 research: mechanisms, tissue targets, published evidence, and the rationale for studying them in combination.
CJC-1295 vs Sermorelin: Half-Life and Efficacy Comparison
A mechanistic and evidence-based comparison of CJC-1295 and Sermorelin as GHRH analogues, examining half-life differences, GH pulse physiology, and published efficacy data.
Ipamorelin vs GHRP-6: Selectivity, Side Effects, and GH Output
A detailed comparison of Ipamorelin and GHRP-6 as GH secretagogues, examining receptor selectivity, cortisol and prolactin effects, appetite stimulation, and published GH output data.
AOD-9604: The C-Terminal Fragment of HGH and Fat Metabolism Research
A review of AOD-9604's origin as a fragment of human growth hormone, its documented lipolytic effects, and the published clinical evidence from Metabolic Pharmaceuticals' trials.
Hexarelin vs Ipamorelin: GH Secretagogue Comparison
A comparison of Hexarelin and Ipamorelin as GH secretagogues, examining potency differences, cardiac effects unique to Hexarelin, and desensitization profiles.
Peptide Stability: How Temperature and pH Affect Research Compounds
A scientific review of the chemical degradation pathways that affect peptide stability, and how temperature, pH, light exposure, and reconstitution conditions influence research compound integrity.
How to Verify Peptide Purity: HPLC vs Mass Spectrometry Explained
A technical explanation of the two primary analytical methods used to verify research peptide purity and identity: HPLC and mass spectrometry, and what to look for in a Certificate of Analysis.
Research-Grade vs Pharmaceutical-Grade Peptides: What's the Difference
A clear explanation of the regulatory, purity, and manufacturing differences between research-grade and pharmaceutical-grade peptides, and what these distinctions mean in practice.
The Recovery Stack: BPC-157 + TB-500 + GHK-Cu Research Overview
A mechanistic analysis of the BPC-157, TB-500, and GHK-Cu combination for tissue repair research, examining how the three compounds target complementary biological pathways.
GH Optimization Stack: CJC-1295 + Ipamorelin + MK-677 Research
A mechanistic analysis of the CJC-1295, Ipamorelin, and MK-677 combination for GH axis research, examining how the three compounds target complementary aspects of GH secretion.
Anti-Aging Protocol: Epithalon + GHK-Cu + NAD+ Research
A mechanistic review of the Epithalon, GHK-Cu, and NAD+ combination for anti-aging research, examining how each compound targets distinct hallmarks of cellular aging.
Cognitive Enhancement Stack: Semax + Selank + NAD+ Research
A mechanistic review of the Semax, Selank, and NAD+ combination for cognitive research, examining how the three compounds target complementary aspects of neurological function.
FDA Regulation of Research Peptides: What Researchers Need to Know
A factual overview of the FDA regulatory framework governing research peptides, including the distinction between research chemicals and drugs, and the legal landscape for peptide research.
Epithalon: Telomere Research and the Khavinson Studies
A review of Epithalon's documented effects on telomere length, telomerase activity, and lifespan in preclinical models, based on the published work of Vladimir Khavinson.
Insulin-Like Growth Factor 1 (IGF-1): Downstream Effects of GH Peptides
A review of IGF-1 biology, its role as the primary mediator of GH peptide effects, and the published research on IGF-1 signaling in muscle, bone, and metabolic tissue.
Nitric Oxide Pathways: BPC-157 and Vascular Research
A review of BPC-157's documented effects on nitric oxide production and eNOS activation, and the implications for vascular and tissue repair research.
Sermorelin vs CJC-1295: Half-Life and Efficacy Comparison
A comparison of Sermorelin and CJC-1295 as GHRH analogues, examining the pharmacokinetic differences that make CJC-1295 more suitable for sustained GH axis stimulation research.
Epithalon vs NAD+: Anti-Aging Peptide Research Compared
A comparison of Epithalon and NAD+ as anti-aging research compounds, examining their distinct mechanisms — telomerase activation vs mitochondrial support — and the evidence base for each.
GHK-Cu vs EGF: Skin Repair Peptide Research Compared
A comparison of GHK-Cu and Epidermal Growth Factor (EGF) as skin repair research compounds, examining their distinct mechanisms and the evidence for each in wound healing and skin rejuvenation research.
GHRP-2 vs GHRP-6: Hunger Side Effects and GH Output Compared
A comparison of GHRP-2 and GHRP-6 as GH secretagogues, examining their relative GH output, hunger-stimulating effects, and cortisol elevation profiles.
Tirzepatide vs Semaglutide: Dual Agonist vs Single Agonist Research
A mechanistic and clinical comparison of Tirzepatide (dual GLP-1/GIP agonist) and Semaglutide (GLP-1 agonist) based on published Phase III trial data.
MK-677 (Ibutamoren): Oral GH Secretagogue Research Overview
A comprehensive review of MK-677 (Ibutamoren) as an orally active GHS-R1a agonist, covering its pharmacokinetics, published clinical trial data, and research applications.
NAD+: Biology, Age-Related Decline, and Research Applications
A comprehensive review of NAD+ biology, the evidence for age-related NAD+ decline, and the published research on NAD+ precursor supplementation in animal models and human clinical trials.
Selank: Anxiolytic Peptide Research and GABAergic Modulation
A review of Selank's pharmacology, including its proposed GABAergic mechanism, BDNF upregulation effects, and the published evidence from Russian clinical trials.
Semax: BDNF Upregulation and Neuroprotection Research
A review of Semax's pharmacology, including its ACTH-derived structure, BDNF upregulation mechanism, and the published evidence for neuroprotective effects in animal models and clinical studies.
Collagen Synthesis Pathways: How Peptides Influence Fibroblast Activity
A review of the molecular pathways governing collagen synthesis in fibroblasts and how research peptides including GHK-Cu, BPC-157, and TB-500 interact with these pathways.
Angiogenesis and Peptide Research: VEGF Pathways
A review of angiogenesis biology and how research peptides including BPC-157, TB-500, and GHK-Cu promote new blood vessel formation through VEGF and related pathways.
The HPA Axis and Peptide Modulation: Stress Response Research
A review of the hypothalamic-pituitary-adrenal (HPA) axis and how research peptides including GHRPs and BPC-157 interact with stress response pathways.
PT-141 (Bremelanotide): Melanocortin Receptor Research
A review of PT-141 (Bremelanotide) as a melanocortin receptor agonist, its FDA approval for hypoactive sexual desire disorder, and the published mechanistic research.
Neurotrophin Signaling: How Peptides May Support BDNF and NGF
A review of neurotrophin biology (BDNF, NGF, NT-3) and how research peptides including Semax, Selank, and BPC-157 interact with neurotrophin signaling pathways.